Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized, blinded, two-arm comparative trial of continued versus limited
isoniazid (INH) tuberculosis (TB) preventive therapy in HIV-infected adults in Gaborone and
Francistown, Botswana. Subjects will be accrued over two years and followed for a minimum of
36 months.
Phase:
Phase 4
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborators:
Botswana Ministry of Health United States Agency for International Development (USAID)